| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.035 | 0.8 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.9 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.03 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.9 |